Hiru Corporation
PINK SHEETS : HIRU

Hiru Corporation

August 18, 2010 07:30 ET

Shaungshi AHP (HIRU) Launches the Jiangxi Shaungshi Biological Medicines Institute

NANCHANG, CHINA--(Marketwire - Aug. 18, 2010) - Hiru Corporation (PINK SHEETS:HIRU) (http://www.hirucorporation.com) subsidiary Jiangxi Shaungshi Pharmaceutical Co., Ltd (Shaungshi AHP) launched the Jiangxi Shaungshi Biological Medicines Institute.

Shuangshi AHP is currently researching several new veterinary drugs for development within the next two years. The company launched this new institute to strengthen and speed up the research and development processes. The Institute will allow the company a better focus and concentration of its talent in bio-tech development and research. Shaungshi AHP has elected Li Rui to be director of the institute.

The company intends to continue its work in the development, production and marketing of both well-established and new veterinary drugs, and nutritional additives (amino acids, vitamins, trace elements, etc.) for the Chinese market.

The company is pleased with this development and looks forward to future growth.

About Mina Mar Group:

Mina Mar Group pioneered the "Go Public Free" program, the first firm to challenge the short sellers, stock bashers and repeal of the "Communication Decency Act". Visit www.minamargroup.com/ice to learn more.

Mina Mar Marketing Group, MMMG (www.minamargroup.net) offers publicly traded companies full array of services such as Investor Relations and maintenance investor awareness.

To be included in company's email database for press releases, "Friday Tips", Monday Analysis industry updates, and company activity that may or may not be news released, please subscribe for opt–in mailer at http://www.minamargroup.com/updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of the Company that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. The Company cautions you that any forward-looking information provided by or on behalf of the Company is not a guarantee of future performance. Please read the full disclosure at this link http://www.minamargroup.com/edisclaimer/ None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind.

Investor Relations:

Tel: 1–647–426–1640; www.minamargroup.net/helpdesk, Investor Relations Department Inquiry, www.minamargroup.net (IR), for (M&A) and Corporate Matters, www.minamargroup.com.

Contact Information